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Abstract
Background: Given the unique role of the corticotrophin-releasing hormone (CRH) system in human fetal development, the
aim of our study was to estimate the association of birth weight with DNA sequence variation in three maternal genes
involved in regulating CRH production, bioavailability and action: CRH, CRH-Binding Protein (CRH-BP), and CRH type 1
receptor (CRH-R1), respectively, in three racial groups (African-Americans, Hispanics, and non-Hispanic Whites).
Methods: Our study was carried out on a population-based sample of 575 mother–child dyads. We resequenced the three
genes in mouse–human hybrid somatic cell lines and selected SNPs for genotyping.
Results: A significant association was observed in each race between birth weight and maternal CRH-BP SNP genotypes.
Estimates of linkage disequilibrium and haplotypes established three common haplotypes marked by the rs1053989 SNP in
all three races. This SNP predicted significant birth weight variation after adjustment for gestational age, maternal BMI,
parity, and smoking. African American and Hispanic mothers carrying the A allele had infants whose birth weight was on
average 254 and 302 grams, respectively, less than infants having C/C mothers. Non-Hispanic White mothers homozygous
for the A allele had infants who were on average 148 grams less than those infants having A/C and C/C mothers.
Conclusions: The magnitudes of the estimates of the birth weight effects are comparable to the combined effects of
multiple SNPs reported in a recent meta-analysis of 6 GWAS studies and is quantitatively larger than that associated with
maternal cigarette smoking. This effect was persistent across subpopulations that vary with respect to ancestry and
environment.
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Introduction
The contribution of genetic and environmental determinants to
variation in birth weight is an area of considerable on-going
interest and investigation. The association of pathophysiological
fetal growth, as reflected by extremes of the birth weight
distribution (small-for-gestational age (SGA) and large-for-gesta-
tional age (LGA) births), with high perinatal morbidity and
mortality has long been established [1]. More recent studies
suggest that variation in the normal range of variation in fetal
growth (birth weight assessed as a quantitative trait) is also
associated with many important developmental and health
outcomes (e.g., childhood and adult blood pressure, body
composition and metabolic function [2,3]).
While much effort has been committed to the identification and
management of pathologically inadequate or pathologically
excessive fetal growth, less effort has been committed to evaluating
the determinants of normal variation in fetal growth and birth
weight. Furthermore, current limitations in knowledge about
factors influencing variation in fetal growth make it difficult to
accurately distinguish the optimally grown from the sub- or supra-
optimally grown infant [4].
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Birth weight, the phenotype representing the culmination of
fetal growth, is a complex, multi-factorial trait regulated by the
interplay of maternal and fetal genes and intrauterine physiology
(endocrine, immune, vascular and other processes). Relatively little
information, however, is currently available about the genetic loci
that explain variation in birth weight. Studies using animal models
have provided important insights regarding the genetic and
environmental determinants of birth weight including the role of
imprinted genes [5]. However, a significant limitation in the ability
to generalize findings from animal models (even among closely-
related mammals) to humans is a consequence of the observed
large inter-species variation in the physiology of pregnancy [6].
One important example of this inter-species variation is exempli-
fied by the corticotrophin-releasing hormone (CRH) family of
proteins.
CRH is the key regulator of the hypothalamic-pituitary-adrenal
axis. It is primarily secreted centrally (in the brain) and exerts
major effects on growth, reproduction, immunity, thyroid function
and metabolism [7,8]. In the context of pregnancy in primates, but
not other mammals, the placenta is a major peripheral site of
CRH production. Placental CRH is released into the maternal as
well as fetal compartments, where it exerts its biological actions.
However, even across primates (e.g., between New and Old World
monkeys and humans), there are large differences in the patterns
of production, activity and regulation of placental CRH and CRH
binding protein [6,9,10].
In human pregnancy CRH is primarily produced in the
decidua, fetal membranes and placenta [11]. CRH production
increases in an exponential manner over the course of human
gestation, and it is released into both maternal and fetal
compartments. A 37-kDa CRH binding protein (CRH-BP) is
produced in all mammals. The primary peripheral source of
human CRH-BP production during pregnancy is the maternal
liver. CRH-BP binds CRH with equal or greater affinity than the
CRH receptors, resulting in dimerization of the protein and
clearance of CRH from the circulation and inhibiting its function
[12,13,14]. This places CRH-BP in an important regulatory
position between CRH and its receptors [15]. Maternal CRH-BP
levels do not change significantly during most of gestation, but
they fall during the final weeks of normal pregnancy [16,17]. CRH
exerts its biological effects by activating two G-protein-coupled
receptors: CRH receptor 1 (CRH-R1), primarily expressed in the
myometrium and fetal membranes, and CRH receptor 2 (CRH-
R2), which has a higher affinity for urocortin and appears to play a
role in vascular control [18,19]. Thus, the genes encoding CRH,
CRH-BP and CRH-R1 represent the key genetic regions
regulating CRH production, bioavailability and activity in the
context of human gestation.
In humans, placental CRH is known to play an important role
in outcomes related to the length of human gestation and timing of
onset of parturition [6,20]. Evidence suggests CRH may also play
a role in fetal growth and birth weight via direct as well as indirect
pathways. We have previously reported that inter-individual
variation in placental CRH production in mid-gestation predicts
variation in birth weight [20]. Other work has demonstrated cross-
sectional associations between variation in birth weight and cord
levels of CRH at birth [21]. Yet other studies have demonstrated
relationships between placental CRH and risk for obstetric
conditions, such as preeclampsia and pregnancy-induced hyper-
tension [22,23,24], that, in turn, are predictive of extreme birth
weight. A recent study convincingly demonstrated that CRH,
acting via the CRH-R1 receptor, stimulates trophoblast produc-
tion of GLUT1 - the rate-limiting determinant of placental glucose
transport – thereby supporting its direct role in fetal growth
[25,26]. Thus, these findings, coupled with findings relating CRH
to other endocrine, immune and vascular processes that are known
to play a role in regulating processes underlying fetal growth,
provide the rationale and biological plausibility for the study
reported here.
Given the importance of elucidating the determinants of birth
weight and the potentially unique role of the CRH system in
human fetal growth and development, we carried out the study
reported here to estimate the association of variation in birth
weight with DNA sequence variation in gene regions coding for
the three key genes regulating CRH production, bioavailability
and action (i.e., CRH, CRH-BP and the CRH type 1 receptor
(CRH-R1), respectively [8,27]. Our study involved a population-
based cohort of mother-child pairs sampled from the three major
racial/ethnic populations in the United States (African Americans,
henceforth denoted Blacks, Hispanics and non-Hispanic Whites,
henceforth denoted Whites).
There are significant differences among racial/ethnic groups for
average birth weight [28]. Although we expect the same genetic
loci and environmental agents to be involved in determining fetal
growth in all pregnancies, the observed average racial/ethnic
differences in birth weight may be explained by racial/ethnic
differences in the relative frequencies and/or sizes of the effects of
variations in these factors. For these reasons, the relative
contribution of variation in genetic and environmental factors to
variation in birth weight within racial/ethnic cannot be taken as
an explanation for differences in average birth weight between
racial/ethnic groups. Hence, our goal here is to identify one or
more genetic variations that explain birth weight variation in all
three racial/ethnic groups.
Because an important goal of clinical research is to identify
measures of risk before, or during pregnancy, we elected here to
investigate the utility of the maternal genotype in explaining
variation in birth weight. We treated birth weight as a quantitative
trait in order to evaluate the determinants of normal, physiological
fetal growth. In addition to the dominant effect of gestational age
at birth, the pursuit of defining the agents that influence fetal
growth has identified a significant contribution of a subset of
predictors of birth weight that include sex of the child and
maternal BMI, race/ethnicity, parity, obstetric risk and smoking
[29]. We therefore included these risk factors in our analyses of the
impact of genetic variation on explaining variation in birth weight.
We addressed the following research questions:
1. Does the CRH pathway-related genetic information explain
variation in birth weight after accounting for the effects of other
established risk factors/determinants of birth weight?
2. Is there CRH-pathway related genetic information that
explains variation in birth weight across the three major
racial/ethnic groups in the U.S.?
Materials and Methods
Study Participants
Participants in our study were recruited at two study sites in
Southern California (the University of California, Irvine, Medical
Center in Orange, CA, and the Cedars Sinai Medical Center in
Los Angeles, CA) and one study site in Pennsylvania (the Magee
Womens Hospital in Pittsburgh, PA). All participants in the
current study participated in one or more clinical studies of
pregnancy outcomes. These study protocols included multiple,
serial assessments of biomedical, biological, psychosocial, and
behavioral processes in pregnancy. Women ,18 years, with
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multiple gestation, cord, placental, or uterine anomalies, fetal
congenital malformations and those whose pregnancies ended in a
spontaneous abortion were ineligible for the study. Beyond study
design, we also restricted the final study dataset to only include
Blacks, Hispanics, and Whites; and removed births ,168 days (24
weeks) gestation. Race/ethnicity was determined by self-report
using the Office of Management and Budget 1997 Revisions to the
Standards for the Classification of Federal Data on Race and
Ethnicity (Revision of Statistical Policy Directive No. 15, Race and
Ethnic Standards for Federal Statistics and Administrative
Reporting). The characteristics of the samples ascertained for
each racial group are presented in Table 1. Our study is based on
the analyses of 575 unique mother-child pairs.
Ethics Statement
All methods and procedures included in the current study were
approved by the UC Irvine Institutional Review Board, the
Cedars-Sinai Medical Center Institutional Review Board, and the
Magee Women’s Hospital Institutional Review Board. All
participants provided written informed consent. This consent
procedure was approved by the institutional review boards of the
participating institutions.
Birth Weight, Gestational Age and Obstetric Risk
Assessment
Information on birth weight was abstracted from the delivery
medical record. For all participants, gestational age was deter-
mined by best obstetric estimate with a combination of last
menstrual period and early uterine size, and was confirmed by
obstetric ultrasonographic biometry using standard clinical criteria
[30]. Obstetric risk was defined as the presence of major medical
complications in the index pregnancy, i.e., vaginal bleeding,
placenta abruptio, pregnancy-induced hypertension, preeclamp-
sia, or infection. Risk conditions were ascertained by extensive
medical chart review and coded as a binary variable (presence or
absence of obstetric risk), as previously described [20]. Gestational
diabetes was considered as a separate obstetric risk factor (and not
part of the composite obstetric risk score) because, unlike the other
obstetric risk conditions, it is associated with higher birth weight.
Procedures
Participants attended multiple, serial study visits during
pregnancy. Study assessments included structured psychosocial
and medical interviews, questionnaires, fetal biometry ultrasound,
and the collection of venous blood, saliva and urine. Maternal
venous blood was collected in Paxgene blood DNA tubes and
samples were stored at 280uC until DNA extraction.
Resequencing and Genotyping
We resequenced the three key genes from the CRH pathway
(CRH, CRH-BP, CRH-R1) in mouse-human hybrid somatic cell
lines constructed from individuals representing three major
American ethnic groups including 20 Africans, 19 Hispanics,
and 20 Whites [31]. The hybrid cell lines were monosomic for
human chromosome 8 (CRH), chromosome 5 (CRH-BP), and
chromosome 17 (CRH-R1). The CRH and CRHBP genes were
sequenced in their entirety. Due to its large size (51.6 kb),
sequencing of CRHR1 was limited to functional regions, including
the 59 proximal promoter region, all exons, and partial intronic
sequences adjacent to exons. We used genomic DNA from the
hybrid cell lines for amplification of overlapping mid-sized
fragments that covered CRH (2 fragments covering 4.4 kb),
CRH-BP (12 fragments covering 18.8 kb), and CRHR1 (17
fragments covering 7.8 kb). These midsize fragments were
sequenced using internal primers (300–500 bp intervals) with
capillary-based methods (ABI DNA Analyzer 3730xl). Table S1A,
B and C show general characteristics of the variants that were
identified in the three genes by resequencing, including locations
within gene regions, major/minor alleles, and minor allele
frequencies for the two ethnic groups. Among these DNA variants
identified by resequencing, we selected SNPs at these three loci for
genotyping in lymphocyte DNA samples from 575 mother-
offspring pairs using the ABI SNPlex platform. We excluded
microsatellites, insertion/deletions, singleton SNPs (MAF,0.01),
and SNPs that were not suitable for genotyping by SNPlex. After
these exclusions, we used genotypic data for 58 SNPs for
subsequent association analysis (9 SNPs for CRH, 30 SNPs for
CRHBP, and 19 SNPs for CRH-R1). These SNPS are summa-
rized in Figure S1 (CRH-BP), Figure S2 (CRH) and Figures S3
and S4 (CRH-R1).
Statistical Analysis Approach and Methodology
SNP allele frequencies were estimated using the gene counting
method and linkage disequilibrium between each pair of SNPs was
defined by the formula presented by Weir [32] and estimated
using an expectation-maximization (EM) algorithm. Tests of 1)
goodness of fit of SNP genotype frequencies to the Hardy-
Weinberg expectations, 2) differences in minor allele frequencies
between races (and between the Southern California and
Pennsylvania samples for each race, and 3) the differences in
each of the discretely defined maternal and infant/birth charac-
teristics between races were carried out using chi-square statistics.
The F-test was employed to evaluate the statistical significance of
the racial differences in the averages of the continuous variables.
Multiple variable linear regression was employed to estimate the
contribution of characteristics of the mother and child to
predicting offspring birth weight in each race. A two stage
statistical strategy was carried out to determine whether a gene
region made a statistically significant contribution to explaining
birth weight variation in all three races. Details are presented in
Supporting Information S1.
Results
A description of the mothers and infants included in our study is
presented in Table 1. We completed studies of 575 mother-child
pairs that were distributed among three racial/ethic groups. Fifty
nine percent (340) of these pairs were recruited from Southern
California and 41% (235) from Pittsburgh, Pennsylvania.
As depicted in Table 1, we observed statistically significant
racial differences for maternal characteristics (except the preva-
lence of diabetes). Parity, sex of the child and the average
gestational age at birth did not vary significantly among races. The
average birth weight of infants of the Black mothers was 227 and
256 grams less than the offspring of Hispanic and White mothers,
respectively.
Estimates of the contribution of variation in sex of child and
characteristics of the mother in determining variation in birth
weight are presented in Table 2 for two models. Model A estimates
the average increase in birth weight for each day of gestational age
and the effect of female sex of the child. Model B estimates the
additional effects of one unit increase in BMI, multiparous status
and smoking. We observed a statistically significant increase in
birth weight per day of gestational age (25.9 to 26.8) and a
statistically significant decrease in birth weight associated with
female sex (2102.9 to 2122.7) in each of the races when Model A
was fitted to the data. There was no statistically significant
Maternal CRH-BP Gene Variation and Birth Weight
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Table 1. Subject characteristics.
Blacks Hispanics Whites Pooled
Mother/child pairs available 188 144 243 575
Recruited from Irvine, CA 54 (28.7) 128 (88.9) 158 (65.0) 340 (59.1)
Recruited from Pittsburgh, PA 134 (71.3) 16 (11.1) 85 (35.0) 235 (40.9)
Maternal Characteristics
Age (years)
Average (SD)*** 26.9 (5.2) 27.6 (5.6) 29.6 (5.8) 28.2 (5.7)
,25 (N, %)*** 79 (42.0) 48 (33.3) 64 (26.3) 191 (33.2)
25–33 (N, %) 81 (43.1) 66 (45.8) 109 (44.9) 256 (44.5)
.33 (N, %) 22 (11.7) 26 (18.1) 67 (27.6) 115 (20.0)
Missing 6 (3.2) 4 (2.8) 3 (1.2) 13 (2.3)
Height (cm)
Average (SD)*** 163.6 (6.8) 160.4 (7.3) 165.0 (6.9) 163.4 (7.2)
Pre-pregnancy Weight (kg)
Average (SD)** 74.7 (18.9) 71.5 (18.3) 69.0 (16.7) 71.4 (18.0)
Pre-pregnancy BMI (kg/m2)
Average (SD)*** 27.8 (6.6) 27.8 (6.9) 25.3 (5.8) 26.8 (6.5)
#19.8 (N, %)** 12 (6.4) 11 (7.6) 29 (11.9) 52 (9.1)
19.8 to 26.0 (N, %) 78 (41.5) 56 (38.9) 127 (52.3) 261 (45.4)
26.1 to 29.0 (N, %) 20 (10.6) 21 (14.6) 32 (13.2) 73 (12.7)
.29.0 (N, %) 70 (37.2) 52 (36.1) 53 (21.8) 175 (30.4)
Missing 8 (4.3) 4 (2.8) 2 (0.8) 14 (2.4)
Parity (N, %)***
Nulliparous 37 (19.7) 46 (31.9) 109 (44.9) 192 (33.4)
Multiparous 146 (77.7) 94 (65.3) 134 (55.1) 374 (65.0)
Missing 5 (2.6) 4 (2.8) 0 (–) 9 (1.6)
Marital Status (N, %)***
Married 80 (42.6) 84 (58.3) 181 (74.5) 345 (60.0)
Not Married 105 (55.8) 56 (38.9) 62 (25.5) 223 (38.8)
Missing 3 (1.6) 4 (2.8) 0 (–) 7 (1.2)
Income (N, %)***
# $10,000 per year 71 (37.8) 10 (6.9) 35 (14.4) 116 (20.2)
$10,000–$50,000 per year 81 (43.1) 64 (44.4) 93 (38.2) 238 (41.4)
. $50,000 per year 10 (5.3) 22 (15.3) 66 (27.2) 98 (17.0)
Missing 26 (13.8) 48 (33.3) 49 (20.2) 123 (21.4)
Education (N, %)***
Less than High School 38 (20.2) 14 (9.7) 21 (8.6) 73 (12.7)
High School/GED 97 (51.6) 48 (33.3) 65 (26.8) 210 (36.5)
Some College 31 (16.5) 47 (32.7) 48 (19.8) 126 (21.9)
College Grad/Post-Graduate 19 (10.1) 33 (22.9) 103 (42.4) 155 (27.0)
Other 2 (1.1) 2 (1.4) 5 (2.0) 9 (1.6)
Missing 1 (0.5) 0 (–) 1 (0.4) 2 (0.3)
Education (N, %)***
Less than High School 38 (20.2) 14 (9.7) 21 (8.6) 73 (12.7)
High School/GED 97 (51.6) 48 (33.3) 65 (26.8) 210 (36.5)
Some College 31 (16.5) 47 (32.7) 48 (19.8) 126 (21.9)
College Grad/Post-Graduate 19 (10.1) 33 (22.9) 103 (42.4) 155 (27.0)
Other 2 (1.1) 2 (1.4) 5 (2.0) 9 (1.6)
Missing 1 (0.5) 0 (–) 1 (0.4) 2 (0.3)
OB Risk Score (N, %)
0 risk conditions 145 (77.1) 102 (70.8) 206 (84.8) 453 (78.8)
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evidence that Model A varied among races (F= 0.03, p = 0.99).
Adding BMI, multiparous status and smoking in Model B
significantly improved the prediction of birth weight in the
samples of Black (p = 0.01) and White mothers (p = 0.006) but not
in the sample of Hispanic mothers (p = 0.20). The size of the
estimates of gestational age effects (26.2 to 26.8) and sex of the
child (288.3 to 2112.4) were essentially unchanged in Model B
compared to Model A, suggesting their effects are independent of
BMI, multiparous status and smoking. Although estimates of the
effects of BMI, multiparous status and smoking and their total
contribution to explaining variation beyond gestational age and
sex of the child varied among races, there was no statistical
evidence that the ability of Model B to explain birth weight
variation varied significantly among races (F = 0.45, p= 0.92).
To provide a comprehensive survey of genetic variation in the
three genes (CRH, CRH-BP, and CRH-R) we selected because
Table 1. Cont.
Blacks Hispanics Whites Pooled
1 risk condition 32 (17.0) 29 (20.1) 26 (10.7) 87 (15.1)
2 risk conditions 4 (2.2) 4 (2.8) 5 (2.0) 13 (2.3)
Missing 7 (3.7) 9 (6.3) 6 (2.5) 22 (3.8)
Diabetes (N, %)
Yes 2 (1.1) 6 (4.1) 6 (2.5) 14 (2.4)
No 181 (96.3) 134 (93.1) 237 (97.5) 552 (96.0)
Missing 5 (2.6) 4 (2.8) 0 (–) 9 (1.6)
Smoking (N, %)***
During Pregnancy 64 (34.1) 18 (12.5) 61 (25.1) 143 (24.9)
Not During Pregnancy 111 (59.0) 120 (83.4) 175 (72.0) 406 (70.6)
Missing 13 (6.9) 6 (4.1) 7 (2.9) 26 (4.5)
Infant/Birth Characteristics
Birth type (N, %)
Spontaneous/Induced/Non-Elective C-Section 173 (92.0) 128 (88.9) 218 (89.7) 519 (90.3)
Elective C-Section 15 (8.0) 16 (11.1) 23 (9.5) 54 (9.4)
Missing 0 (–) 0 (–) 2 (0.8) 2 (0.3)
Sex (N, %)
Male 103 (54.8) 77 (53.5) 128 (52.7) 308 (53.6)
Female 85 (45.2) 67 (46.5) 115 (47.3) 267 (46.4)
Gestation Age at Birth (days)
Average (SD) 271.4 (15.2) 271.6 (16.7) 274.2 (12.1) 272.6 (14.4)
Birth Weight (g)
Average (SD)*** 3151.5 (569.7) 3378.5 (617.8) 3407.1 (545.7) 3316.4 (582.8)
*a=0.05.
**a= 0.01.
***a= 0.001.
doi:10.1371/journal.pone.0043931.t001
Table 2. Risk factor effects on birth weight in grams.
Blacks (N=173) Hispanics (N=138) Whites (N=234)
Trait Model A1 Model B2 Model A Model B Model A Model B
Gestation age/day +26.0*** +26.2*** +25.9*** +26.8*** +26.8*** +26.6***
Female Child 2102.9* 288.3 2122.7* 2110.9 2107.1* 2112.4**
BMI/(kg/m2) +10.4** +1.3 +4.1
Multiparous +76.7 +169.7** +98.7*
Smoked during pregnancy 2130.5** 215.7 2200.5***
1Model A: Birth weight =Gestation Age + Child Sex.
2Model B: Birth weight =Gestation Age + Child Sex + Pre-pregnancy BMI + Parity + Smoking.
*Prob#0.10.
**Prob#0.05.
***Prob#0.01.
doi:10.1371/journal.pone.0043931.t002
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they are involved in regulating the CRH pathway, we resequenced
cell lines derived from 20 Blacks, 19 Hispanics, and 20 Whites
representative of the three racial/ethnic groups included in our
study. Tables S1, S2 and S3 present information on the identity,
position, and relative allelic frequencies of the SNP variants
characterized in these cell lines. Figures S1, S2, S3 and S4 give the
relative frequencies of the minor allele for each of the SNPs
identified by the resequencing that were selected for genotyping in
the 173 Black, 138 Hispanic and 234 White mothers who
participated in our study.
The results of the analyses to evaluate the contribution of SNP
variation to explaining birth weight variation beyond the
traditional risk factors are presented in Tables 3 and 4 for each
of the three gene regions. Each of the three gene regions made a
significant contribution to explaining birth weight variation in
Blacks. Two gene regions (CRH-BP and CRH-R1) made a
significant contribution to variation in Hispanics and one region
(CRH-BP) made a significant contribution in Whites (Table 3).
The contribution of the genotypes determined by the selected
SNPs to explaining birth weight variation ranged from 3.45% and
1.55% for models A and B, respectively, for White infants to
12.39% and 6.11% for models A and B, respectively, for Black
infants. SNP variation in the CRH-BP gene region explained
6.11%, 9.53% and 1.55% of birth weight variation adjusted for
the complete set of risk factors in Blacks, Hispanics and Whites,
respectively. The SNPs that were selected to represent the
contribution of each gene region to explaining variation in birth
weight beyond that explained by either Model A or Model B for
each race are listed in Table 4.
On the basis of the results of the analyses presented in Tables 3
and 4 we next turned to identifying a subset of SNPs that
represented the CRH-BP gene region in all three races. Six SNPs
were selected to mark genetic variation in Blacks, nine were
selected in Hispanics, and three in Whites (Table 4). Three SNPs
each marked significant variation in Blacks and Hispanics, and
one SNP (rs1053989) marked significant variation in all three
races. The location of these SNPs is presented in Figure S1A. A
search for the tag SNPs that represent variation in the CRH-BP
gene region identified rs1053989 in each of the races.
Table 5 presents the estimates of the genotype effects of SNP
rs1053989 for Model A and Model B. The pattern of the size of
the genotype effects and their statistical significance are essentially
the same for models A and B, i.e., they are independent of whether
BMI and parity and smoking are in the model. The estimates of
genotype effects when Model B is considered that are presented in
Table 5 are plotted in Figure 1, where the relative frequencies of
the three genotypes are included.
The A allele explains a large and statistically significant
dominant effect on the decrease in birth weight in Blacks (A/
A=3173, A/C=3075, C/C=3378) and Hispanics (A/A=3323,
A/C=3224, C/C=3552) and a recessive effect in Whites (A/
A=3291, A/C=3436, C/C=3442). Those Black and Hispanic
mothers carrying the A allele had infants whose birth weight was
on average 254 and 302 grams, respectively, less than infants
having C/C mothers. Those White mothers homozygous for the A
allele had infants who were on average 148 grams less than those
infants having A/C and C/C mothers. The relative frequency of
the A allele in Black mothers was significantly greater than in
Hispanic and White mothers (Figure 1). Black mothers carried the
A allele (relative frequency = 0.703) approximately twice as often
as the Hispanic (relative frequency = 0.356) and White mothers
(relative frequency = 0.402).
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Discussion
In our study of the relation between birth weight and sequence
variation in the CRH family of genes, we found that variation in
the 39 untranslated region (UTR) of the CRH-BP gene, marked by
SNP rs1053989, explained a significant amount of variation in
birth weight in Whites, Hispanics and Blacks. The influence of
sequence variation in the CRH-BP gene on birth weight in our
study is similar in magnitude to the reported influence of cigarette
smoking [33] and about half that of maternal cocaine use [34]. In
Table 4. SNPs with significant effects beyond risk factors on birth weight.
Blacks (N=173) Hispanics (N=138) Whites (N=234)
Gene Region Model A1 Model B2 Model A Model B Model A Model B
CRHBP rs41272246 rs41272246 rs41272246
rs32897
76255599*
rs7718461 rs7718461 rs7718461 rs7718461
rs7728378 rs7728378 rs7728378 rs7728378
rs75319082
rs7721519 rs7721519
rs10055255 rs10055255 rs10055255 rs10055255
rs1875999 rs1875999
rs1053989 rs1053989 rs1053989 rs1053989 rs1053989
rs2135078 rs2135078
rs2174444 rs2174444
CRH rs12721510
rs28364018 rs28364018
CRHR1 rs12936511 rs12936511
rs28364028 rs28364028 rs28364028 rs28364028
1Model A: Birth weight =Gestation Age + Child Sex + SNP.
2Model B: Birth weight =Gestation Age + Child Sex + Pre-pregnancy BMI + Parity + Smoking + SNP.
*GRCh37.2 position (no rs number assigned for this SNP).
doi:10.1371/journal.pone.0043931.t004
Figure 1. Birth weight means in grams for CRH-BP SNP rs1053989 genotypes. Birth weights adjusted by length of gestation, child sex,
maternal BMI, parity, smoking.
doi:10.1371/journal.pone.0043931.g001
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our view, in contrast to the pathologic nature of the exposures of
smoking and cocaine, common variation in the CRH-BP gene is
more likely to represent a physiologic contribution to birth weight.
This speculation deserves directed evaluation in prospective
fashion, with particular attention to the postnatal implications of
birth weight as a relevant phenotype.
With respect to previous explorations of the genetic contribution
to birth weight, Freathy et al conducted a meta-analysis of six
genome-wide association studies of newborn genotype and
identified two loci (rs900400 near LKR1 and CCNL1, and
rs9883204 in ADCY5)[35]. These investigators estimated that
newborns carrying four ‘‘birth weight-lowering’’ alleles were 113
grams smaller at birth than newborns carrying zero or one of these
alleles. Our present investigation identified sequence variation
with a contribution to birth weight at least as large or larger than
the four allele model identified by Freathy et al. Further, our
candidate gene approach with a targeted survey of a physiological
pathway influencing fetal growth identified sequence variation in
the CRH-BP gene not identified in the GWAS meta-analysis
approach. Of note, our findings are in maternal genotype while
those of Freathy et al are in the newborn genome. The genome-
wide association approach and the candidate gene approach, in
this instance, produce complementary findings that together
permit insights into birth weight provided by neither approach
alone. Our finding of a maternal gene variant influencing newborn
birth weight is an example of an indirect maternal genetic effect
[36]. These effects are important in understanding the develop-
ment of an individual’s phenotype as well as understanding the
evolution of the genetic architecture responsible for that pheno-
type.
The effect was observed across the three racial/ethnic groups,
suggesting that this genetic effect, while variable in magnitude, is
persistent across subpopulations that vary with respect to ancestry
and environment. Confidence in a gene-phenotype association is
enhanced when that association is present across groups of
individuals that vary with respect to geography, ancestry, and
environment.
The effect of CRH-BP sequence variation on birth weight is
unchanged after adjusting for maternal BMI, parity, and smoking,
suggesting that this variation represents an independent contribu-
tion to fetal growth beyond those clinical and epidemiological
factors commonly used in attempts to explain variation in birth
weight [29]. While these, and other, environmental factors may
exert an influence on fetal growth, and, thus, birth weight, our
adjusted analyses suggest that our identified genetic effect is not
explained by unmeasured confounding from these factors.
The biological mechanisms linking CRH-BP to fetal growth
and birth weight are unknown. In human pregnancy, maternal
Table 5. Estimates of effects of mother’s risk factors and mother’s genotype (CRHBP SNP rs1053989) on infant birth weight in
grams.
Risk Factors Model A
Blacks (N=172) Hispanics (N=136) Whites (N=226)
Pooled
(N=534)
Race (Black) – – – 2133***
Race (Hispanic) – – – +37
GA (per day) +27*** +27*** +27*** +27***
Sex (female) 294 299 2103* 2101***
CRHBP rs1053989
A/A 2239* 2239** 2210*** 2184***
A/C 2330*** 2353*** 230 2186***
C/C Reference Reference Reference Reference
Risk Factors Model B
Blacks (N=172) Hispanics (N=136) Whites (N=226) Pooled (N=534)
Race (Black) – – – 2159***
Race (Hispanic) – – – 24
GA (per day) +27*** +27*** +27*** +27***
Sex (female) 278 285 2110** 298***
BMI (per unit) +9** 22 +4 +5*
Parity (multiparous) +86 +135* +92 +92**
Smoking (yes) 2141** 212 2199*** 2145***
CRHBP rs1053989
A/A 2215* 2241** 2154* 2155***
A/C 2312** 2341*** 28 2168***
C/C Reference Reference Reference Reference
*Prob#0.10.
**Prob#0.05.
***Prob#0.01.
doi:10.1371/journal.pone.0043931.t005
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CRH is related to offspring birth weight and fat mass [37]. We
speculate that CRH-BP may regulate bioavailability of CRH
and thus influence fetal growth. The molecular function of
rs1053989 has been described in the literature. SNP rs1053989
alters a putative binding site for microRNA miR33a in the 39
UTR of CRH-BP (exon 7) (CAAAGCAACGTGCAATA C/A
AA)[38]. Interestingly, rs1053989 disrupts the miR33a ‘‘seed’’
sequence (CAATA C/A A) that must be perfectly complemen-
tary for binding of microRNAs with recognition sites in 39
UTRs of targeted genes. This evolutionarily conserved micro-
RNA is encoded within intron 16 of the gene for sterol-
responsive element-binding protein 2 transcription factor
(SREBP2 on chromosome 22) that regulates cholesterol
homeostasis. Previous functional studies have shown that
miR33a regulates expression of genes in cellular pathways of
cholesterol transport, including ABCA1 (ATP binding cassette
transporter) and the lysosomal transporter protein NPC1
(Niemann-Pick disease, type C1) [39–40]. This microRNA is
co-expressed with SREBP2 in many different tissues including
placenta, indicating that miR33a may be a global regulator of
cholesterol transport and metabolism [39]. Maternal cholesterol
is associated with fetal growth; maternal levels of HDL
cholesterol are inversely related to infant birth weight [41].
ABCA1 is present in human placenta and is localized largely at
the basolateral and to some extent at the apical side of first
trimester villous cytotrophoblast cell membranes [42]. Placental
expression of ABCA1 is thought to play an important role in
maternal-fetal cholesterol transfer. A recent study that assessed
the expression profile of miRNAs and their predicted target
genes in placentas from preeclampsia and preterm labor (both
of which are associated with decreased birth weight) reported
altered expression of a number or miRNAs associated several
target genes including CRH and CRH-BP [43].
This finding raises the opportunity for future study, and,
possibly, patient care advances. Our data do not permit insight
into the relative contribution of CRH-BP sequence variation to
the various components of newborn weight such as skeletal, lean
and fat mass. Further study of the body composition of
newborns and the influence of genotype will serve to further
dissect biological mechanism of influence. The contribution of
sequence variation in the CRH-BP gene to physiologic and
pathologic variation in the growth of the human fetus ought to
be assessed prospectively in a population of women with
rigorously ascertained environmental contributors to birth
weight. Our finding also raises the possibility that sequence
variation in CRH-BP might influence the clinical ability of
assessment of fetal growth to distinguish the fetus with
pathologic growth from the fetus with physiological growth
restriction/impairment. Observational and randomized trials are
warranted to evaluate the clinical utility of birth weight
customization models that include genotype to distinguish
newborns at risk for adverse outcome from those not at risk
for adverse outcome. Current strategies show promise in this
regard but are limited by their inability to explain sufficient
physiological variation in birth weight. This is particularly an
issue in attempts to identify the small-for-gestational-age and
large-for-gestational-age newborns at risk for adverse outcome
[4,44]. The incorporation of genotype into antenatal customiza-
tion models may add precision and clinical utility to these tools
for assessing the adequacy of fetal growth.
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